Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study.
Garssen
M P J
MP
Erasmus MC, Department of Neurology, Room BA450, PO Box 1738, 3000 DR Rotterdam, The Netherlands [corrected]
van Koningsveld
R
R
van Doorn
P A
PA
Merkies
I S J
IS
Scheltens-de Boer
M
M
van Leusden
J A
JA
van Schaik
I N
IN
Linssen
W H J P
WH
Visscher
F
F
Boon
A M
AM
Faber
C G
CG
Meulstee
J
J
Prick
M J J
MJ
van den Berg
L H
LH
Franssen
H
H
Hiel
J A P
JA
van den Bergh
P Y K
PY
Sindic
C J M
CJ
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D020275:Guillain-Barre Syndrome / Q000188:drug therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives*; D010865:Pilot Projects
D000893:Anti-Inflammatory Agents; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D008775:Methylprednisolone
Cochrane Database Syst Rev. 2004;(1):CD002063
14973982
Neurology. 2001 Jan 9;56(1):94-6
11148242
Lancet. 2004 Jan 17;363(9404):192-6
14738791
J Peripher Nerv Syst. 2005 Jun;10(2):94-112
15958123
Neurology. 2004 Aug 24;63(4):715-7
15326250
Ann Neurol. 1990;27 Suppl:S21-4
2194422
Lupus. 2005;14 Suppl 1:s42-5
15803931